Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
05/01 11:01 am
Benzinga
Read moreWhy the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge
03/08 08:33 am
Benzinga
Read moreOncology Breakthroughs: How Cancer Research Is Advancing in 2025
02/27 11:04 am
Benzinga
Read moreInvestors Eye Biotech Sector as Cancer Therapy Market Surges
02/19 11:06 am
Benzinga
Read moreCutting-Edge Cancer Therapies Lead the Way into a Transformative Year
01/15 11:10 am
Benzinga
Read moreRegulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data
01/15 08:02 am
Benzinga
Read moreOncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment
12/26 12:26 pm
Benzinga
Read moreBiotech Advances Drive Cancer Research as Global Rates Continue Upward Trend
12/02 11:18 am
Benzinga
Read moreOptimism Grows in the Fight Against Cancer as Breakthroughs and Funding Increase
09/24 09:15 am
Benzinga
Read moreCancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players
09/19 12:08 pm
Benzinga
Read moreOncolytics Biotech (ONCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
06/04 09:55 am
Zacks Investment Research
Read moreGilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
04/22 01:57 pm
Zacks Investment Research
Read moreBristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
04/22 01:56 pm
Zacks Investment Research
Read moreNovartis (NVS) to Report Q1 Earnings: What to Expect?
04/19 10:10 am
Zacks Investment Research
Read moreAfter Plunging -29.54% in 4 Weeks, Here's Why the Trend Might Reverse for Oncolytics Biotech Inc. (ONCY)
08/17 09:35 am
Zacks Investment Research
Read more5 Analysts Have This to Say About Oncolytics Biotech
06/29 03:00 pm
Benzinga
Read moreExpert Ratings for Oncolytics Biotech
05/26 05:01 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
05/24 11:00 am
Benzinga
Read moreNew Strong Buy Stocks for January 18th
01/18 09:12 am
Zacks Investment Research
Read moreIs DICE Therapeutics (DICE) Stock Outpacing Its Medical Peers This Year?
12/16 10:40 am
Zacks Investment Research
Read more2 Sector ETFs Hovering Around a 52-Week High
12/06 02:00 pm
Zacks Investment Research
Read moreWhat Makes Oncolytics Biotech Inc. (ONCY) a Strong Momentum Stock: Buy Now?
12/05 01:00 pm
Zacks Investment Research
Read moreOncolytics (ONCY) Up on Lead Drug Securing 2nd FDA Fast Track Tag
12/02 11:59 am
Zacks Investment Research
Read moreOncolytics Biotech Inc. (ONCY) Hit a 52 Week High, Can the Run Continue?
12/02 10:15 am
Zacks Investment Research
Read moreNasdaq Turns Lower; Dow Tumbles Over 300 Points
12/01 01:09 pm
Benzinga
Read moreIs Olink Holding (OLK) Outperforming Other Medical Stocks This Year?
11/29 10:40 am
Zacks Investment Research
Read moreOncolytics Biotech Inc. (ONCY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
11/18 10:55 am
Zacks Investment Research
Read more5 Penny Stocks To Buy According To Analysts, Targets Up To 995%
11/08 03:21 pm
PennyStocks
Read moreBenzinga's Top Ratings Upgrades, Downgrades For October 6, 2022
10/06 10:25 am
Benzinga
Read moreZacks.com featured highlights include Boot Barn, Canada Goose, Pediatrix Medical Group, Leap Therapeutics and Oncolytics Biotech
07/11 06:19 am
Zacks Investment Research
Read moreRide on Rising P/E Investing With These 5 Top-Ranked Stocks
07/08 07:52 am
Zacks Investment Research
Read moreThe Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO
03/03 08:46 am
Benzinga
Read moreThe Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
02/02 08:33 am
Benzinga
Read more4 Penny Stocks To Buy For Under $4 Right Now
01/19 01:22 pm
PennyStocks
Read moreThe Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
12/06 07:07 am
Benzinga
Read moreOncolytics Biotech (ONCY) Sees Hammer Chart Pattern: Time to Buy?
12/03 07:25 am
Zacks Investment Research
Read moreHere's Why Oncolytics Biotech Inc. (ONCY) Could be Great Choice for a Bottom Fisher
12/01 11:00 am
Zacks Investment Research
Read more5 Stocks With Rising P/E Are Good Buys
12/01 09:22 am
Zacks Investment Research
Read moreDown 23.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Oncolytics Biotech Inc. (ONCY)
11/19 11:00 am
Zacks Investment Research
Read moreHere's Why Oncolytics Biotech Inc. (ONCY) is Poised for a Turnaround After Losing 19.6% in 4 Weeks
08/18 10:00 am
Zacks Investment Research
Read moreThe Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
08/06 07:42 am
Benzinga
Read more